login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Ra Pharmaceuticals Inc (RARX) Stock News
NASDAQ:RARX - Nasdaq -
47.995
-0.02 (-0.03%)
After market: 47.995
0 (0%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RARX Latest News, Press Relases and Analysis
All
Press Releases
5 years ago - By: Seeking Alpha
- Mentions:
APLS
ALXN
BCRX
AKTX
...
Apellis on go to file U.S. application for pegcetacoplan for rare blood disorder (NASDAQ:APLS)
5 years ago - By: Zacks Investment Research
Is RA PHARMCTL INC (RARX) Stock Outpacing Its Medical Peers This Year?
5 years ago - By: Zacks Investment Research
How Ra Pharmaceuticals (RARX) Stock Stands Out in a Strong Industry
5 years ago - By: Benzinga
- Mentions:
OPK
XBI
ATHX
HSIC
...
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests
5 years ago - By: Benzinga
- Mentions:
ASTC
USAU
Stocks That Hit 52-Week Highs On Wednesday
5 years ago - By: StockNews.com
- Mentions:
VIR
GH
EBS
BJ
...
Best & Worst Performing Mid Cap Stocks for March 12, 2020
5 years ago - By: Analyst Ratings
- Mentions:
ARNA
Analysts Offer Insights on Healthcare Companies: Ra Pharmaceuticals (NASDAQ: RARX) and Arena Pharma (NASDAQ: ARNA)
5 years ago - By: Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals Supports 13th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases
5 years ago - By: Seeking Alpha
Ra Pharmaceuticals EPS misses by $0.16
5 years ago - By: Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
5 years ago - By: Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals Announces Publication of Zilucoplan Phase 2 gMG Trial Results in JAMA Neurology
6 years ago - By: Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals Announces Clearance of IND Application for the HEALEY ALS Platform Trial
6 years ago - By: Zacks Investment Research
- Mentions:
ALKS
INVA
ANIK
Ra Pharmaceuticals Begins Phase II Study on Autoimmune Drug
6 years ago - By: Seeking Alpha
Ra Pharma commences mid-stage study of zilucoplan in rare type of myopathy
6 years ago - By: Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of Zilucoplan for IMNM
6 years ago - By: Halper Sadeh LLP
- Mentions:
IPHS
FOMX
Merger Investigation Alert: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - IPHS, FOMX, RARX
6 years ago - By: Seeking Alpha
Ra Pharmaceuticals EPS misses by $0.05, beats on revenue
6 years ago - By: Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
6 years ago - By: CNBC
- Mentions:
IBB
AMGN
CELG
BIIB
...
Biotech stocks win October, rallying 8%
Please enable JavaScript to continue using this application.